Greenlight Guru & bioaccess Partner Together to Accelerate Product Development and Navigate the Regulatory Landscape to Get to the LATAM and Global Market Faster and Improve Patient Outcomes.
Customers benefit from leading eQMS and industry-dedicated contract research organization (CRO) and market access consulting firm
[ORLANDO, FL, May 3, 2022] – Greenlight Guru and bioaccess™ share the same goal and mission: To enhance the quality of life by helping Medtech manufacturers get to market faster, with less risk. Greenlight Guru and bioaccess™ announce their cooperation agreement to bring medical device companies closer to Latin America and conduct early-stage clinical trials or sell their innovations.
Greenlight Guru has realized that Medtech companies use outdated, generic, inefficient tools. Greenlight Guru has created the only purpose-built platform to give medical technology companies an end-to-end software solution to bring life-changing products to patients. With Greenlight Guru, medical device manufacturers have a single source of truth empowering both product and quality teams that streamlines collaboration and compliance without stifling product development efforts.
bioaccess™ tackled another challenge in the industry: Foreign Medtech companies struggle to find an investigator for their early-feasibility clinical studies and a way to sell their innovations in Latin America. These companies are unfamiliar with the region. They lack in-house experts to help them operationalize a successful clinical, regulatory, or commercial market access strategy to ensure long-term success in Latin America. Since 2010, bioaccess™ has provided clinical research and market access consulting services to foreign medical device manufacturers looking to succeed in Latin America with their first-in-human clinical trials and the commercialization of their innovations in the region.
"Now with bioaccess™ as a partner, our customers will now have streamlined resources for bringing their innovations to Latin America: a vast untapped region full of opportunities for fast, cost-effective, and quality early-feasibility clinical research, and a promising market for the commercialization of medical technologies," said David DeRam, CEO of Greenlight Guru.
Both Greenlight Guru and bioaccess™ are leading the industry to provide solutions built specifically for the Medtech industry. The partnership presents Medtech companies with industry-specific out-of-the-box software solutions to automate quality, regulatory, and product development and industry-specific clinical research and market access solutions to ensure their long-term success in Latin America.
###
About Greenlight Guru
Greenlight Guru is the only purpose-built platform to give medical technology companies an end-to-end software solution to bring life-changing products to patients. The platform integrates cross-functional teams, processes, and data throughout the entire product lifecycle, giving visibility and traceability beyond compliance requirements to proactively overcome execution gaps and accelerate success. Thousands of Medtech professionals are using Greenlight Guru’s platform across the globe to push beyond baseline compliance and achieve True Quality for their medical devices. For more information, visit www.greenlight.guru.
About bioaccess™
bioaccess™ is a US-based contract research organization (CRO), regulatory, and market access consulting company that delivers a full spectrum of offerings from bench to commercialization so that foreign medical device companies can have long-term success in Colombia and the rest of Latin America. For more information, visit www.bioaccessla.com.
Media contact
bioaccess.™
Julio G. Martinez-Clark, +1 (954) 903-7210
Chief Executive Officer
jmclark@bioaccessla.com
Greenlight Guru
Naomi Gollmer (419) 518-0067
Content/PR Specialist
naomi.gollmer@greenlight.guru